158 related articles for article (PubMed ID: 12004326)
61. Autoimmune Skin Conditions: Autoimmune Blistering Disease.
Helm M; Helm LA; Clebak KT; Foulke G
FP Essent; 2023 Mar; 526():13-17. PubMed ID: 36913658
[TBL] [Abstract][Full Text] [Related]
62. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D
J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
[TBL] [Abstract][Full Text] [Related]
63. [Pemphigoid vegetans. An immunoelectron microscopic study].
Delpuget-Bertin N; Bernard P; Bedane C; Boulinguez S; Garnier A; Bonnetblanc JM
Ann Dermatol Venereol; 1997; 124(6-7):467-9. PubMed ID: 9739912
[TBL] [Abstract][Full Text] [Related]
64. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia.
Maki N; Demitsu T; Umemoto N; Nagashima K; Nakamura T; Kakurai M; Nakamura S; Yamada T; Ishii N; Hashimoto T
J Dermatol; 2016 May; 43(5):571-4. PubMed ID: 26507447
[TBL] [Abstract][Full Text] [Related]
65. A case of juvenile bullous pemphigoid--successful treatment with diaminodiphenylsulfone and prednisone.
Marcus KA; Halbertsma FJ; van Steensel MA
Pediatr Dermatol; 2009; 26(1):55-8. PubMed ID: 19250407
[TBL] [Abstract][Full Text] [Related]
66. The immunofluorescence evaluation of some subepidermal bullous diseases by use of NaCl-split skin.
Salavec M; Nozicka Z; Rozsívalová V; Pavlátová J
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1994; 37(2):67-71. PubMed ID: 7784801
[TBL] [Abstract][Full Text] [Related]
67. Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients.
Chiorean RM; Baican A; Mustafa MB; Lischka A; Leucuta DC; Feldrihan V; Hertl M; Sitaru C
Front Immunol; 2018; 9():2687. PubMed ID: 30524436
[No Abstract] [Full Text] [Related]
68. Case with Brunsting-Perry-like localized subepidermal blister formations and immunoglobulin G antibodies against unidentified basement membrane zone antigen.
Sato-Shibuya M; Dainichi T; Egawa G; Honda T; Otsuka A; Ishii N; Hashimoto T; Miyachi Y; Kabashima K
J Dermatol; 2016 Apr; 43(4):426-8. PubMed ID: 26362108
[TBL] [Abstract][Full Text] [Related]
69. Immunoglobulin A antibodies against desmoglein 1, envoplakin, periplakin and BP230 in a patient with atypical bullous pemphigoid.
Yamaki F; Mayuzumi N; Ikeda S; Hashimoto T
J Dermatol; 2010 Mar; 37(3):255-8. PubMed ID: 20507390
[TBL] [Abstract][Full Text] [Related]
70. Alterations of basement membrane zone in autoimmune subepidermal bullous diseases.
Woźniak K; Kowalewski C
J Dermatol Sci; 2005 Dec; 40(3):169-75. PubMed ID: 15990279
[TBL] [Abstract][Full Text] [Related]
71. Diagnosis and classification of autoimmune blistering diseases.
Baum S; Sakka N; Artsi O; Trau H; Barzilai A
Autoimmun Rev; 2014; 13(4-5):482-9. PubMed ID: 24434358
[TBL] [Abstract][Full Text] [Related]
72. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180.
Skaria M; Salomon D; Jaunin F; Friedli A; Saurat JH; Borradori L
Dermatology; 1999; 199(3):253-5. PubMed ID: 10592407
[TBL] [Abstract][Full Text] [Related]
73. Childhood localized vulvar pemphigoid is a true variant of bullous pemphigoid.
Saad RW; Domloge-Hultsch N; Yancey KB; Benson PM; James WD
Arch Dermatol; 1992 Jun; 128(6):807-10. PubMed ID: 1599268
[TBL] [Abstract][Full Text] [Related]
74. Familial autoimmune enteropathy with circulating anti-bullous pemphigoid antibodies and chronic autoimmune hepatitis.
Lachaux A; Bouvier R; Cozzani E; Loras-Duclaux I; Kanitakis J; Chevallier M; Kaiserlian D
J Pediatr; 1994 Dec; 125(6 Pt 1):858-62. PubMed ID: 7996356
[TBL] [Abstract][Full Text] [Related]
75. [Treatment of lichen planus pemphigoides with acitretin and pulsed corticosteroids].
Kolb-Mäurer A; Sitaru C; Rose C; Bröcker EB; Goebeler M; Zillikens D
Hautarzt; 2003 Mar; 54(3):268-73. PubMed ID: 12634997
[TBL] [Abstract][Full Text] [Related]
76. Vesicular pemphigoid with circulating autoantibodies against 230-kDa and 180-kDa proteins, and additional autoantibodies against 97-kDa and 45-kDa proteins.
Lai FJ; Sheu HM; Lee JY; Cheng CL; Chen W
Int J Dermatol; 2007 Feb; 46(2):206-9. PubMed ID: 17269979
[TBL] [Abstract][Full Text] [Related]
77. [Bullous pemphigoid: diagnostics and new therapeutic strategies].
Hofmann SC; Bruckner-Tuderman L
Dtsch Med Wochenschr; 2006 Feb; 131(8):389-92. PubMed ID: 16479471
[TBL] [Abstract][Full Text] [Related]
78. Treatment and clinical outcomes in anti-p200 pemphigoid: a systematic review.
Laufer Britva R; Amber KT; Cohen AD; Kridin K
J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):465-472. PubMed ID: 31536652
[TBL] [Abstract][Full Text] [Related]
79. Case of bullous pemphigoid coexisting with anti-desmoglein autoantibodies.
Tie D; Yoshida T; Chinuki Y; Da X; Ishikawa N; Morita E
J Dermatol; 2017 Jul; 44(7):822-825. PubMed ID: 28342216
[TBL] [Abstract][Full Text] [Related]
80. Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations.
Yancey KB; Egan CA
JAMA; 2000 Jul; 284(3):350-6. PubMed ID: 10891967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
